specialty-chemical

German specialty-chemical group Lanxess slid 5.2%.

Europe's Markets Tilt Higher Barbara Kollmeyer 2011

The specialty-chemical maker's fiscal second-quarter profit dropped 59%, hurt by higher raw-material costs and lower overall volumes.

DJIA Notches Third Gain Brendan Conway 2011

Eastman Chemical Co. said Friday it has agreed to buy specialty-chemical maker Solutia Inc. for about $3.4 billion in a move that executives see paying off as auto, construction and consumer-electronics markets recover.

Eastman Chemical to Buy Solutia Doug Cameron 2012

There's no dearth of acquirers for a specialty-chemical company like Switzerland-based Clariant, or other vulnerable companies such as Belgium's Umicore SA and France's Rhodia SA.

Clariant's Süd-Chemie Bid May Exact Too High a Price 2011

The specialty-chemical maker's fiscal second-quarter profit dropped 59%, hurt by higher raw-material costs and lower overall volumes.

DJIA Notches Third Gain Brendan Conway 2011

Revenue from specialty-chemical sales helped Blue Fire make the case for a commercial-scale 20 million-gallon-a-year refinery in Fulton, Miss., that investors initially were wary of funding, says Mr. Klann.

Taking the Fuel Out of Biofuels Ben Lefebvre 2011

Tom Pennington/Getty Images Flames engulfed the specialty-chemical plant, owned by a privately held maker of chemical products for use in the energy, agriculture and construction industries.

Fire at Texas Chemical Plant 2011

The day's biggest decliner among Stoxx 600 components was Swiss specialty-chemical group Clariant , which plummeted 16% after it cut its full-year sales and profit outlook because of the strong Swiss franc and the global economic slowdown.

European Stocks Slammed Barbara Kollmeyer 2011

W.R. Grace & Co . split its Grace Davision business into two operating segments, a move the specialty-chemical company said would help it align more closely with its markets and reduce overhead costs.

W.R. Grace Splits Grace Davison Business Into Two Mia Lamar 2012

If board members believe cancer treatment crimps a leader's performance, the CEO should "take a break — as long as the board and the CEO agree," suggests Raj Gupta, retired head of Rohm & Haas Co., a specialty-chemical concern acquired by Dow Chemical Co. last year.

CEOs With Cancer Force Tough Choices Joann S. Lublin 2010